ISCO.OB successfully manufactured its 1st scaled-up lots of stem cell-based skin creams, Read more…
ASTM announced that Ronald Cresswell, PhD, Hon DSc,FRSE has joined the board of directors. Read more…
The California Institute for Regenerative Medicine (CIRM) approved funding for 19 awards worth $67M Read more…
KOOL has entered into a license and distribution agreement for its Res-Q™ 60 BMC (Res-Q) System with BioParadox, Read more…
ASTM has submitted to the FDA, a special protocol assessment (SPA) describing the proposed Phase 3 clinical development program in critical limb ischemia (CLI). Read more…
BTIM will unveil 12 new cell lines to be launched 11/1/10. Read more…
Cytori will host its Q3/10 results conference call on Thursday, 11/4/10 at 2:00 PM PT/5:00 PM ET. Read more…
iPS Academia Japan has agreed to give Cellectis SA of France access to its patents on how to create stem cells for medical treatment. Read more…
Research from Rockefeller University shows that having too many stem cells or stem cells that live for too long, can increase the odds of developing cancer. Read more…
ASTM has granted fast track designation for their critical limb ischemia (CLI) cell therapy development program. Read more…
Founder and Director of Research, Henry McCusker enters his eighth (8) year at Scimitar Equity with past experience in sell-side analysis, buy-side management, corporate management and due diligence.